The U.S. unit of Indian drugmaker Dr. Reddy’s Laboratories is recalling 331,590 bottles of cinacalcet tablets used to treat hyperparathyroidism due to the presence of a known carcinogen. The company ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), announced ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and ...
India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy — next year, joining ...
HYDERABAD July 23 (Reuters) - Dr Reddy's Laboratories (REDY.NS), opens new tab plans to launch a cheaper copycat version of Novo Nordisk's (NOVOb.CO), opens new tab blockbuster weight-loss drug Wegovy ...
A pre-approval inspection by the FDA of Dr. Reddy’s Bachupally biologics production facility earlier this month resulted in the drugmaker being issued a Form 483. The FDA reprimand, which was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results